SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-17-005987
Filing Date
2017-10-06
Accepted
2017-10-06 18:30:13
Documents
1
Period of Report
2017-10-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-39919.html 4  
1 PRIMARY DOCUMENT marketforms-39919.xml 4 7372
  Complete submission text file 0001214659-17-005987.txt   8804
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Christensen Jamie (Reporting) CIK: 0001599324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 171128327